// App-Quantinova.ai

PO‐095 : Clinical profile of long responders (>36 months) to lenalidomide based therapy in multiple myeloma in a single centre

Researchers

Presenter

  • M Joffe

Principal Investigators

  • S Halasag

  • A Nicholds

  • C Clarke

  • C Morrow

  • G Asagba

  • L Barton

  • M Garg

  • R Krishna

Medical Centers

  • Hematology

  • Rheumatology, University Hospitals of Leicester, Leicester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 79A

  • Immunoglobulin G

Drug/Treatment

  • Lenalidomide

  • Thalidomide

  • Bortezomib

  • Vorinostat

  • Lanthanum carbonate

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved